![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BIOPURE AVOIDS SEC FINE
BIOPURE AVOIDS SEC FINE
September 13, 2006
Biopure Corp. won't have to pay penalties to settle allegations it touted the prospects for a synthetic blood product without disclosing that drug regulators had concerns about the product's safety, the Securities and Exchange Commission said Tuesday.
Yahoo
Finance
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct